James Gilbert is listed as a director on 3 SEC Form D filings by 3 issuers between Feb 2013 and Oct 2018: KSQ Therapeutics, Inc. (Cambridge, MA — pharmaceuticals — 2018; $80.6M reported sold to 16 investors), TransMedics, Inc. (Andover, MA — other health care — 2016; $63.7M reported sold to 26 investors) and Charity Partners Inc. (Boston, MA — industry reported as "Other" — 2013; $11.8M reported sold to 63 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 5 years. Across those companies the filings report $156.1M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for James Gilbert and found 8 differences, 1 worth asking the sponsor about: Form D filed 816 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.